A. Rocha-Sousa, F. Falcão-Reis, A. F. Leite-Moreira
Current Eye Research, Volume 33, Issue 1 January 2008 , pages 73 - 79
(link)
Background:
Obestatin is a 23aa amidated peptide derived from preproghrelin, a product of the ghrelin gene. It is known to activate a rodopsin type G-coupled receptor (GPR-39), with binding sites in the GI tract and both the pituitary and hypothalamus. It tends to be co-localized with acetylcholine in the myenteric plexus, which provides innervation to the smooth muscles of the GI tract. Therefore it may be a regulator of cholinergic muscle contraction.
Ghrelin is a 28aa peptide also produced from the ghrelin gene. It is found in the GI tract, pituitary and hypothalamus, and ghrelin mRNA has been found in the iris posterior epithelium and non-pigmented ciliary epithelial cells in rat's eyes. It has been suggested that ghrelin acts on smooth muscles and it has been implicated in relaxation of the iris sphincter and dilator muscles.
There is evidence that obestatin and ghrelin may have opposite effects in metabolic and GI function. For example, ghrelin stimulates feeding in some animals and increases during fasting, while obestatin injections suppress weight gain and delay gastric emptying.
Iris sphincter muscle contraction is mediated by acetylcholine release and can be modulated by the action of several peptides and hormones. Iris dilator muscle contraction is controlled by the adrenergic system whose modulation is less well known.
This study aims to describe the effects of obestatin and ghrelin on contraction and relaxation of iris sphincter and dilator muscles.
Methods:
Iris sphincter (n=60) and dilator (n=48) muscles were isolated from New Zealand white rabbits (Oryctolagus cuniculus) and immersed in a buffer solution. The ends of each muscle were tied with silk thread and mounted horizontally, one end connected to an electromagnetic length-tension transducer. Muscles were allowed to extend until length remained constant and muscle tension stabilized.
1-5 human ghrelin (a 5aa fragment acting as ghrelin agonist) and human obestatin were used.
First iris sphincter and dilator muscle contractions were elicited by addition of either carbachol (acetylcholine agonist, 10^-6M) or epinephrine (10^-4M), respectively. Then the bath was washed out and after the muscles were stabilized for 5 minutes a second contraction was induced in the additional presence of either obestatin (10^-5M) or 1-5 ghrelin (10^-5M). Muscle tensions generated in the second versus the first contraction of iris sphincter and dilator muscles were compared to the vehicle (control, no obestatin/ghrelin added). This process was repeated using muscle contraction elicited by electric field stimulation (EFS) of 10V, 100Hz during 1ms instead of carbachol or epinephrine.
Finally concentration-response curves were generated by recording muscle tension of iris sphincter and dilator muscles with increasing concentrations of 1-5 ghrelin and obestatin (between 10^-9 and 10^-5M), expressing effects on muscle tension as percent change from initial value.
Results:
Figure 1: Representative example of iris sphincter muscle active tension in two consecutive carbachol-elicited contractions in the absence or presence of: (1) the vehicle (Panel A); (2) obestatin (10-5 M; Panel B); or (3) ghrelin (10-5 M; Panel C). (Rocha-Sousa et al., 2008)
Effects of obestatin and ghrelin on active tension produced by carbachol-induced contractions of iris sphincter muscle (Figures 1 and 2)
- No significant difference in 1st contraction among 3 groups
- Significant (p<0.05) increase (19.0 +/- 10.2%) in presence of obestatin
- Decrease in vehicle-only (11.5 +/- 5.5%) but insignificant (p=0.06)
Figure 2: Iris sphincter muscle tension (upper panel) of two consecutive carbachol-induced (10-6 M) contractions in the absence (first contraction, left column) or presence (second contraction, right column) of the vehicle alone (n= 8), obestatin (10-5 M; n= 10) or ghrelin (10-5 M; n= 7). The lower panel represents the percent tension variation from the first to the second contraction in the same experimental conditions (p < 0.05: *second versus first contraction). (Rocha-Sousa et al., 2008)
Effects of obestatin and ghrelin on active tension produced by epinephrine-induced contractions of iris dilator muscle (Figure 3)
- No significant difference in 1st contraction among 3 groups
- Decrease (10.7 +/- 2.7%, p<0.05) in vehicle-alone
- No significant change with addition of obestatin or ghrelin
Figure 3: Iris dilator muscle tension (upper panel) of two consecutive epinephrine-induced (10-4 M) contractions in the absence (first contraction, left column) or presence (second contraction, right column) of the vehicle alone (n=8), obestatin (10-5 M; n=8) or ghrelin (10-5 M; n=8). The lower panel represents the percent tension variation from the first to the second contraction in the same experimental conditions (p < 0.05: *second versus first contraction). (Rocha-Sousa et al., 2008)
Effects of obestatin and ghrelin on active tension produced by electric field stimulation-induced contractions of iris sphincter muscle (Figure 4)
- No significant difference in 1st contraction among 3 groups
- No significant differences between 1st and 2nd contractions in vehicle-only and obestatin-added groups
- Decrease (0.86 +/- 0.06 mN, p<0.05) with addition of ghrelin
Figure 4: Iris sphincter muscle tension (upper panel) of two consecutive EFS-elicited contractions in the absence (first contraction, left column) or presence (second contractions, right column) of the vehicle alone (n = 8), obestatin (10-5 M; n = 8) or ghrelin (10-5 M; n = 8). The lower panel represents the percent tension variation from the first to the second contraction in the same experimental conditions (p < 0.05: **second versus first contraction). (Rocha-Sousa et al., 2008)
Effects of increasing obestatin/ghrelin concentrations on basal muscle tension
- No significant differences in resting tensions at baseline
- Only ghrelin significantly altered sphincter muscle tension, decreasing 21.7 +/- 3.7% at 10^-5M (p<0.05 vs control)
- Only obestatin significantly altered dilator muscle tension, decreasing 14.1 +/- 5.0% at 10^-5M (p<0.05 vs control)
Figure 5: Concentration-response curves of obestatin (10-9–10-5M) and ghrelin (10-9–10-5M) on the basal tension of the iris sphincter (upper panel) and dilator (lower panel) muscles (p < 0.05: *versus control). (Rocha-Sousa et al., 2008)
Summary of results:
In iris sphincter muscles:
- Obestatin potentiates cholinergic contraction elicited by carbachol
- Ghrelin decreases basal tension in a concentration-dependent manner
- Ghrelin decreases tension developed in EFS-elicited contraction
In iris dilator muscles:
- Obestatin decreases basal tension in a concentration-dependent manner
Critique:
The figures were simple and clearly demonstrated the differences in muscle tension generated in all treatments of iris muscle contractions, including their significance.
The experiment provides convincing evidence that obestatin and ghrelin may have opposite effects on muscle contraction and relaxation in the iris sphincter muscles. Obestatin appears to potentiate cholinergic contraction in a similar mechanism to that proposed for the GI tract, although it had an opposite relaxing effect on the iris dilator muscles. The evidence suggests that obestatin is moreso involved in pupil constriction while ghrelin is involved in dilation, but ghrelin failed to show any direct action on the iris dilator muscles.
A possible reason for a lack of response to ghrelin in iris dilator muscles is the fact that a 5aa fragment of human ghrelin is used in the experiment. Perhaps a fragment so small or even a complete human peptide would be insufficient to stimulate the applicable Oryctolagus receptor so a possible effect in vivo cannot be ruled out. Since both obestatin and 1-5 ghrelin were obtained from human sources it is possible that both peptides may have different affinities to the foreign receptors so actual increases or decreases in muscle tension in vivo cannot be quantified from this experiment. However, the fact remains that some effects were seen and this is strong evidence for involvement of both obestatin and ghrelin in mediation of iris sphincter and dilator muscles.
References:
Rocha-Sousa A., Falcão-Reis F., Leite-Moreira A.F. 2008 The Obestatin/Ghrelin System as a Novel Regulatory Mechanism of Iris Muscle Contraction. Current Eye Research, 33(1):73-79